How much does imatinib cost in Australia?
IMATINIB
| Code & Prescriber | Medicinal Product Pack (Name, form & strength and pack size) | General Patient Charge |
|---|---|---|
| 9112N | IMATINIB imatinib 400 mg tablet, 30 (PI, CMI) | $41.30 |
| Available brands | ||
| Glivec |
What is the brand name for imatinib mesylate?
Gleevec is the trade name for the generic drug name Imatinib Mesylate. STI-571 is another name for Imatinib Mesylate. In some cases, health care professionals may use the trade name Gleevec or other name STI-571 when referring to the generic drug name Imatinib Mesylate.
What is the monthly cost of Gleevec?
In 2017, a month’s supply of Gleevec cost about $9000, and the cost of generic imatinib was about $8000.
Who makes imatinib mesylate?
Teva Pharmaceutical Industries has announced the launch of a generic version of imatinib mesylate, which is currently manufactured by Novartis and is sold under the brand name Gleevec.
Is imatinib on PBS?
At its March 2011 meeting, the PBAC recommended listing imatinib on the PBS as an Authority Required benefit for the adjuvant treatment of a patient at high risk of recurrence following complete resection of primary GIST at a dose not exceeding 400 mg per day for a period of 12 months on the basis of an acceptable cost …
Is imatinib the same as Gleevec?
Is Gleevec a TKI?
Drugs known as tyrosine kinase inhibitors (TKIs) that target BCR-ABL are the standard treatment for CML. These include: Imatinib (Gleevec)
How expensive is imatinib?
The average cost responsibility for branded imatinib for commercially insured patients was $147 per month. and their cost decreased to $85 per month after generic imatinib became available. For Medicaid patients, the costs were $14 per month for branded imatinib followed by a $7 per month cost for generic imatinib.
What is imatinib mesylate used for?
Imatinib mesylate is approved to treat: Acute lymphoblastic leukemia in adults and children that is Philadelphia chromosome positive. In adults, it is used for disease that has recurred (come back) or is refractory (does not respond to treatment).
Is imatinib mesylate cytotoxic?
Therefore, imatinib (Gleevec) is selective in leukemia. 4,5 It is cytotoxic to Bcr-Abl-containing leukemia cells and thus, selectively cytotoxic.
Is imatinib an immunotherapy?
Immunotherapy with monoclonal antibodies, such as ipilimumab, may help the body’s immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Imatinib mesylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
What conditions does imatinib mesylate treat?
Acute lymphoblastic leukemia in adults and children that is Philadelphia chromosome positive.
Is imatinib chemo?
Gleevec ® (imatinib mesylate) is a prescription medication that contains imatinib mesylate, a tyrosine kinase inhibitor. Tyrosine kinase inhibitors are a class of chemotherapy medicines. Gleevec is approved for the treatment of certain types of cancer, including: Leukemia and other cancers of the blood and bone marrow.
What is the abbreviation for imatinib mesylate?
What is the abbreviation for Imatinib Mesylate? Imatinib Mesylate is abbreviated as IM (also Imatinib, IMA, IMM, IMT or STI-571)